Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-07-11
1993-03-09
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514369, 514370, 514371, 548187, 548193, 548194, 548195, 548198, 548202, 548203, 548204, 548205, A61K 31425, C07D27730
Patent
active
051927810
ABSTRACT:
The present invention relates to the derivatives of formula (I): ##STR1## and their addition salts, and to their use in therapeutics, especially for the treatment of cardiovascular diseases and in particular for the treatment of hypertension and cardiac insufficiency.
REFERENCES:
patent: 5071864 (1991-12-01), Rendenbech-Mueller
patent: 5073562 (1991-12-01), Djuric
Chemical Abstracts, vol. 105, No. 23, Dec. 8, 1986, Columbus, Ohio, US; Abstract No. 208866F.
Bru-Magniez Nicole
Launay Michele
Teulon Jean-Marie
Gerstl Robert
Laboratoires UPSA
LandOfFree
Thiazole derivatives which are angiotensin II receptor antagonis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazole derivatives which are angiotensin II receptor antagonis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazole derivatives which are angiotensin II receptor antagonis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-211779